BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Everist Genomics 

401 W. Morgan Road

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-929-9575 Fax: 866-625-8218


SEARCH JOBS
Everist Genomics is driving growth by developing innovative prognostics with potential for substantive impact on medical and financial outcomes. Our strategy centers on proprietary research and development, targeted acquisitions, and in-licensing. Everist Genomics is currently developing a range of products aimed at improving treatment outcomes in Cancer and Cancer Supportive Care, Cardiovascular Disease, Metabolic Disease (e.g. diabetes) and Neurodegenerative Diseases (e.g. Alzheimer’s and Parkinson’s disease).

 Key Statistics


Email: CustomerService@EveristGenomics.com
Ownership: Private

Web Site: Everist Genomics
Employees:
Symbol: 
 



Industry
Diagnostics






 Company News
Everist Genomics Awarded Admission to Johnson & Johnson (JNJ)'s Life Science Innovation Center 7/11/2012 9:50:42 AM    More...
Everist Genomics Announces Publication of Validation Study Confirming OncoDefender-CRC Independently Predicts Recurrence Risk for Early Stage Colorectal Cancer Patients 6/5/2012 10:10:03 AM    More...
Everist Genomics Forms JV Targeting Indian Market 5/22/2012 11:05:58 AM    More...
Everist Genomics Develops World's First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer 3/14/2012 10:31:26 AM    More...
Everist Genomics Celebrates Origins and Future of Personalized Medicine 2/13/2012 10:20:12 AM    More...
Smartphone Technology Meets Personalized Medicine in Everist Genomics' CardioDefender Diagnostic System 1/30/2012 9:38:06 AM    More...
Everist Genomics Discovers Genes Responsible for Recurrence of Colorectal Cancer 12/7/2011 9:56:37 AM    More...
Everist Genomics Announces Acquisition of Angiologix, Inc. 10/31/2011 10:52:57 AM    More...
Everist Genomics Announces New Data on OncoDefender™- CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients 6/3/2011 10:19:44 AM    More...
Everist Genomics Announces Worldwide Availability of OncoDefender(TM)-CRC 3/28/2011 6:44:03 AM    More...
12

//-->